Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease

Amanda L. Porter; Christian C. Prusinski; Evelyn Lazar; Clara Yuh; Robert C. Bucelli; Brian S. Appleby; Gregory S. Day

doi:10.1001/jamanetworkopen.2022.1556

Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease

Amanda L. Porter, Christian C. Prusinski, Evelyn Lazar, Clara Yuh, Robert C. Bucelli, Brian S. Appleby, Gregory S. Day

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e221556
Journal	JAMA Network Open
Volume	5
Issue number	3
DOIs	https://doi.org/10.1001/jamanetworkopen.2022.1556
State	Published - Mar 9 2022

Access to Document

10.1001/jamanetworkopen.2022.1556

Cite this

@article{e47bf0f48e084c629530ca234512a75c,

title = "Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease",

author = "Porter, {Amanda L.} and Prusinski, {Christian C.} and Evelyn Lazar and Clara Yuh and Bucelli, {Robert C.} and Appleby, {Brian S.} and Day, {Gregory S.}",

note = "Funding Information: Funding/Support: Funding was provided by the National Institutes of Health (grant K23AG064029). Funding Information: Author Contributions: Dr Day had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Prusinski, Bucelli, Day. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Porter, Prusinski, Lazar, Day. Critical revision of the manuscript for important intellectual content: Porter, Prusinski, Yuh, Bucelli, Appleby, Day. Statistical analysis: Prusinski, Lazar, Day. Obtained funding: Appleby, Day. Administrative, technical, or material support: Prusinski, Bucelli. Supervision: Prusinski, Yuh, Bucelli, Appleby, Day. Conflict of Interest Disclosures: Dr Bucelli reported receiving personal fees from Biogen consulting and serving on the advisory board, an annual recurring gift from a patient for neuralgic amyotrophy research, personal fees from and equity in Neuroquestions LLC, and has served on an advisory board for MT Pharma. Dr Appleby reported receiving grants from the Centers for Disease Control and Prevention during the conduct of the study; grants from National Institutes of Health, Ionis, CJD Foundation, and Alector; personal fees from Acadia and Sangamo outside the submitted work; and royalties from Wolters Kluwer. He serves as a consultant for Acadia and Ionis, and he is the medical director of the CJD Foundation (uncompensated). Dr Day reported owning stock in ANI Pharmaceuticals; he serves as a consultant for Parabon Nanolabs, as a Topic Editor (Dementia) for DynaMed (EBSCO), and as the Clinical Director of the Anti-NMDA Receptor Encephalitis Foundation (Inc, Canada; uncompensated). No other disclosures were reported.",

year = "2022",

month = mar,

day = "9",

doi = "10.1001/jamanetworkopen.2022.1556",

language = "English",

volume = "5",

journal = "JAMA Network Open",

issn = "2574-3805",

number = "3",

}

TY - JOUR

T1 - Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease

AU - Porter, Amanda L.

AU - Prusinski, Christian C.

AU - Lazar, Evelyn

AU - Yuh, Clara

AU - Bucelli, Robert C.

AU - Appleby, Brian S.

AU - Day, Gregory S.

N1 - Funding Information: Funding/Support: Funding was provided by the National Institutes of Health (grant K23AG064029). Funding Information: Author Contributions: Dr Day had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Prusinski, Bucelli, Day. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Porter, Prusinski, Lazar, Day. Critical revision of the manuscript for important intellectual content: Porter, Prusinski, Yuh, Bucelli, Appleby, Day. Statistical analysis: Prusinski, Lazar, Day. Obtained funding: Appleby, Day. Administrative, technical, or material support: Prusinski, Bucelli. Supervision: Prusinski, Yuh, Bucelli, Appleby, Day. Conflict of Interest Disclosures: Dr Bucelli reported receiving personal fees from Biogen consulting and serving on the advisory board, an annual recurring gift from a patient for neuralgic amyotrophy research, personal fees from and equity in Neuroquestions LLC, and has served on an advisory board for MT Pharma. Dr Appleby reported receiving grants from the Centers for Disease Control and Prevention during the conduct of the study; grants from National Institutes of Health, Ionis, CJD Foundation, and Alector; personal fees from Acadia and Sangamo outside the submitted work; and royalties from Wolters Kluwer. He serves as a consultant for Acadia and Ionis, and he is the medical director of the CJD Foundation (uncompensated). Dr Day reported owning stock in ANI Pharmaceuticals; he serves as a consultant for Parabon Nanolabs, as a Topic Editor (Dementia) for DynaMed (EBSCO), and as the Clinical Director of the Anti-NMDA Receptor Encephalitis Foundation (Inc, Canada; uncompensated). No other disclosures were reported.

PY - 2022/3/9

Y1 - 2022/3/9

UR - http://www.scopus.com/inward/record.url?scp=85126077846&partnerID=8YFLogxK

U2 - 10.1001/jamanetworkopen.2022.1556

DO - 10.1001/jamanetworkopen.2022.1556

M3 - Article

C2 - 35262719

AN - SCOPUS:85126077846

SN - 2574-3805

VL - 5

JO - JAMA Network Open

JF - JAMA Network Open

IS - 3

M1 - e221556

ER -

Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease

Access to Document

Other files and links

Cite this